According to filings with the U.S. Securities and Exchange Commission, Adaptilens is raising up to $16,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Liane Clamen played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Adaptilens
Adaptilens is the only IOL that imitates the human eyes natural lens. We are a team of ophthalmologists, cataract specialists, scientists, and engineers with a singular focus on improving the vision and quality of life of cataract patients. We are developing an accommodating IOL with novel polymers to give patients the ability to focus not just on a single distance but on objects near, far, and in between–without the help of glasses or contact lenses.

To learn more about Adaptilens, visit http://adaptilens.com/

Contact:
Liane Clamen, Chief Executive Officer
617-680-6888
https://www.linkedin.com/in/liane-clamen/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.